DAVIS STEPHEN Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
30
Insider Sells Sum
$38.62M

Insider Activity of DAVIS STEPHEN

Biography of DAVIS STEPHEN

No biography is available at this moment.

2024-08-19SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
31,747
0.0186%
$15.28$485,094+9.58%
2024-05-02SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
11,427
0.0069%
$16.94$193,573-4.45%
2024-04-08SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
26,574
0.0162%
$17.87$474,877-6.12%
2024-03-27SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
17,714
0.0106%
$17.90$317,081-7.83%
2024-02-26SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
5,577
0.0032%
$24.67$137,585-34.86%
2024-01-08SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
3,732
0.0023%
$29.96$111,811-43.98%
2023-10-06SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
51,563
0.0319%
$21.96$1.13M-15.06%
2023-07-14SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
100,000
0.0575%
$30.04$3M-28.67%
2023-07-12SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
55,104
0.0329%
$25.05$1.38M-11.12%
2023-07-11SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
16,498
0.0102%
$25.00$412,450-7.22%
2023-05-01SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
7,806
0.0047%
$21.18$165,331+10.67%
2023-04-06SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
8,582
0.0052%
$18.16$155,849+31.23%
2023-02-24SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
3,851
0.0024%
$18.78$72,322+26.96%
2023-01-09SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
3,904
0.0024%
$17.13$66,877+35.53%
2022-10-15SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
2,804
0.0017%
$15.81$44,331+27.66%
2022-04-29SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
5,483
0.0033%
$18.18$99,691-8.95%
2022-02-23SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
3,928
0.0023%
$23.80$93,486-32%
2022-01-06SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
3,718
0.0023%
$23.05$85,700-28.22%
2021-10-18SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
2,963
0.0018%
$17.41$51,586+7.05%
2021-04-30SaleACADIA Pharmaceuticals Inc.
ACAD
CEO
7,850
0.0048%
$20.33$159,591+6.52%
Total: 30
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.